Literature DB >> 3624783

Development of a reconstituted water medium and preliminary validation of the frog embryo teratogenesis assay--Xenopus (FETAX).

D A Dawson, J A Bantle.   

Abstract

A reconstituted water medium was developed for use in the Frog Embryo Teratogenesis Assay--Xenopus (FETAX). FETAX solution was then tested on three compounds with known mammalian teratogenicity (ethanol, caffeine, and 5-fluorouracil) as was a non-teratogen (saccharin). The results obtained were then compared with results from tests on these compounds in two other media that had previously been used in the assay. Saccharin was not teratogenic. Ethanol and caffeine were weak and moderate teratogens, respectively. 5-fluorouracil was a strong teratogen. The results compare favorably with those obtained in mammalian studies. The amount of growth inhibition in embryos in the 96 h tests was positively correlated with the degree of teratogenicity of the compound. Final validation of FETAX will allow it to be used to screen and rank compounds for further testing and as a tool for studying the basic mechanisms of teratogenesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3624783     DOI: 10.1002/jat.2550070403

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  18 in total

1.  Synergism and antagonism induced by three carrier solvents with t-retinoic acid and 6-aminonicotinamide using FETAX.

Authors:  J R Rayburn; D J Fort; R McNew; J A Bantle
Journal:  Bull Environ Contam Toxicol       Date:  1991-04       Impact factor: 2.151

2.  Impact of tire debris on in vitro and in vivo systems.

Authors:  Maurizio Gualtieri; Manuela Andrioletti; Paride Mantecca; Claudio Vismara; Marina Camatini
Journal:  Part Fibre Toxicol       Date:  2005-03-24       Impact factor: 9.400

3.  Developmental malformation of frog embryos: an analysis of teratogenicity of chemical mixtures.

Authors:  M A Shirazi; D A Dawson
Journal:  Arch Environ Contam Toxicol       Date:  1991-08       Impact factor: 2.804

4.  Teratogenicity of Ni2+ in Xenopus laevis, assayed by the FETAX procedure.

Authors:  S M Hopfer; M C Plowman; K R Sweeney; J A Bantle; F W Sunderman
Journal:  Biol Trace Elem Res       Date:  1991-06       Impact factor: 3.738

5.  Effects of chlorocresol (4-chloro-2-methyl phenol) administered during the fertilization and cleavage phases of Xenopus laevis.

Authors:  C Vismara; G Bernardini; L Bordone; O Spinelli; A Teruzzi; C Rossetti
Journal:  Bull Environ Contam Toxicol       Date:  1995-08       Impact factor: 2.151

6.  Ecotoxicological effects of a nonionic detergent (Triton DF-16) assayed by modFETAX.

Authors:  C Presutti; C Vismara; M Camatini; G Bernardini
Journal:  Bull Environ Contam Toxicol       Date:  1994-09       Impact factor: 2.151

7.  A Case Study Application of the Aggregate Exposure Pathway (AEP) and Adverse Outcome Pathway (AOP) Frameworks to Facilitate the Integration of Human Health and Ecological End Points for Cumulative Risk Assessment (CRA).

Authors:  David E Hines; Stephen W Edwards; Rory B Conolly; Annie M Jarabek
Journal:  Environ Sci Technol       Date:  2017-12-29       Impact factor: 9.028

8.  Acute and sub-chronic toxicity of four cytostatic drugs in zebrafish.

Authors:  Róbert Kovács; Katalin Bakos; Béla Urbányi; Judit Kövesi; Gyöngyi Gazsi; Andrea Csepeli; Ádám János Appl; Dóra Bencsik; Zsolt Csenki; Ákos Horváth
Journal:  Environ Sci Pollut Res Int       Date:  2015-07-24       Impact factor: 4.223

9.  Effects of specific dosages of magnesium and zinc on the teratogenicity of cadmium, nickel, and cobalt in Xenopus embryos, as assessed by the FETAX test.

Authors:  Ayper Boga; Seref Erdogan; Yasar Sertdemir
Journal:  Dose Response       Date:  2007-01-22       Impact factor: 2.658

10.  Joint actions of carboxylic acid binary mixtures on Xenopus embryo development: comparison of joint actions for malformation types.

Authors:  D A Dawson
Journal:  Arch Environ Contam Toxicol       Date:  1994-08       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.